Upper Limb DisabilityNCT07338955
Validating and Assessing Reliability
An observational study of Upper Limb Disability, run by Bahria University at 1 site in Pakistan.
Trial summary
This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Read more about this study
- Who is it for?
- Ages 18 to 45 years
- Conditions the study is for
- Upper Limb Disability
- What is being tested?
- All participants (Aviane) and data collection
- How many people
- 385 participants
- Where
- 1 sitePakistan
- Study dates
- 3 Nov 2025to 20 Jan 2026
- How long will I take part?
- 385 Weeks
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 45 years
- All sexes
- No healthy volunteers
- Adult
Study population: Patients with upper limb disability or pain for more than 4 weeks
Who may be able to join
- Diagnosed with any upper limb disability or deformity . Able to read, understand and speak Urdu. Individuals with symptoms enduring for at least one week .
Who cannot join
- Cognitive impairment or psychiatric illness that hinders understanding of the questionnaire.
- Patients with congenital deformities. Refusal to give informed consent.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Pakistan1 site, 1 recruiting
- Recruiting
University
Karachi, Sindh, 75300
Muhammad Usman, Masters in Physiotherpy, +923333172771, usman.bumdc@gmail.com
Rabia Khan, Masters in Physiotherapy
About this study
Official title: Validating and Assessing Reliability of the Urdu Version of the Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire.
This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Since no validated Urdu version currently exists, Urdu-speaking patients face communication barriers that may lead to inaccurate assessment and limited clinical decision-making. By ensuring semantic equivalence through forward-backward translation and expert review, the study seeks to develop a version that is both linguistically accurate and culturally appropriate.
Read the detailed description
This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Since no validated Urdu version currently exists, Urdu-speaking patients face communication barriers that may lead to inaccurate assessment and limited clinical decision-making. By ensuring semantic equivalence through forward-backward translation and expert review, the study seeks to develop a version that is both linguistically accurate and culturally appropriate.
A cross-sectional research design will be used, involving adults aged 18-45 years diagnosed with upper limb functional limitations. Participants will complete both the Urdu and English DASH questionnaires to evaluate reliability and validity. Reliability will be assessed through internal consistency (Cronbach's alpha) and test-retest stability (ICC), while validity will be examined using expert scoring (CVI) and correlation with the original instrument. Data analysis will follow standard psychometric testing procedures using SPSS.
The expected outcome is a reliable, valid tool for assessing upper extremity disability in Urdu-speaking populations. This will improve clinical assessment, enhance patient communication, and support broader inclusion in rehabilitation research and practice.
- Conditions
- Upper Limb Disability
- Being tested
- All participants (Aviane), data collection
- Keywords
- Validation and Reliability of DASH Questionnaire
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
All participants (Aviane)Other
Data will be collected from patients having upper limb pain or disability
data collectionOther
Data will be collected from patients having upper limb pain or disbility
| Study group | Role | What they receive |
|---|---|---|
| Group 1 | Data will be collected from experienced physiotherpist Receives: Other: All participants (Aviane); Other: data collection |
What is being measured
The primary outcome is the main question the study is designed to answer.
reliability and validity
To assess the reliability and validity of the Urdu version of the DASH Questionnaire.
Measured: December 2025 to January 2026
Secondary outcomes (1)
cultural adaptation
To ensure the cultural adaptation, response of the patient and to compare the results of DASH Questionnaire Urdu version with English version of DASH Questionnaire.
Measured: October 2025 to November2025
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Jan 2026
- Study start3 Nov 2025
- Primary completion10 Dec 2025
- Study completion20 Jan 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Upper Limb DisabilityStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 385 participants (estimated)
- Target duration
- 385 Weeks
Sponsor and investigators
- Lead sponsor
- Bahria University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Rabia Khan, Bahria University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07338955
- Sponsor's protocol ID
- BUHS-ERC#001\DPT\25
- Status last verified
- Jan 2026
- First submitted
- 4 Dec 2025
- Last updated
- 14 Jan 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Basakci Calik B, Demir P, Gur Kabul E, Caglayan BC, Keskin A, Karasu U. Validity and Reliability of the Turkish Version of the DASH-TR Questionnaire in Rheumatoid Arthritis Patients, Based on Rasch Analysis. Int J Rheum Dis. 2022 Aug;25(8):851-860. doi: 10.1111/1756-185X.14358. Epub 2022 Jun 6.
PubMed 35665605Puentes Gutierrez AB, Garcia Bascones M, Jimenez Diaz F, Cuena Boy R, Puentes Gutierrez R. [Validity and reliability of DASH questionnaire in women who suffer from lymphedema as a side effect of a breast cancer treatment]. Rehabilitacion (Madr). 2023 Jul-Sep;57(3):100780. doi: 10.1016/j.rh.2022.100780. Epub 2023 Feb 3. Spanish.
PubMed 36739630
Study at a glance
From the registry record, last updated by the sponsor on 14 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Validating and Assessing Reliability of the Urdu Version of the Disabilities of the Arm, Shoulder, and Hand (DASH) Questionnaire.
- ClinicalTrials.gov ID
- NCT07338955
- Acronym / sponsor ID
- BUHS-ERC#001\DPT\25
- Conditions
- Upper Limb Disability
- Keywords
- Validation and Reliability of DASH Questionnaire
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 385 participants (estimated)
- Lead sponsor
- Bahria UniversityUniversity, hospital or other
- Study start
- 3 Nov 2025 (actual)
- Primary completion
- 10 Dec 2025 (actual)
- Study completion
- 20 Jan 2026 (estimated)
- First posted
- 14 Jan 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Since no validated Urdu version currently exists, Urdu-speaking patients face communication barriers that may lead to inaccurate assessment and limited clinical decision-making. By ensuring semantic equivalence through forward-backward translation and expert review, the study seeks to develop a version that is both linguistically accurate and culturally appropriate.
Detailed description
This study aims to translate, culturally adapt, and validate the Urdu version of the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire for individuals with upper limb disabilities. Since no validated Urdu version currently exists, Urdu-speaking patients face communication barriers that may lead to inaccurate assessment and limited clinical decision-making. By ensuring semantic equivalence through forward-backward translation and expert review, the study seeks to develop a version that is both linguistically accurate and culturally appropriate.
A cross-sectional research design will be used, involving adults aged 18-45 years diagnosed with upper limb functional limitations. Participants will complete both the Urdu and English DASH questionnaires to evaluate reliability and validity. Reliability will be assessed through internal consistency (Cronbach's alpha) and test-retest stability (ICC), while validity will be examined using expert scoring (CVI) and correlation with the original instrument. Data analysis will follow standard psychometric testing procedures using SPSS.
The expected outcome is a reliable, valid tool for assessing upper extremity disability in Urdu-speaking populations. This will improve clinical assessment, enhance patient communication, and support broader inclusion in rehabilitation research and practice.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 385 Weeks
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Group 1 | – | Other: All participants (Aviane), Other: data collectionData will be collected from experienced physiotherpist |
Who may qualify
- Ages
- 18 to 45 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Patients with upper limb disability or pain for more than 4 weeks
Key inclusion criteria (1 listed)
- Diagnosed with any upper limb disability or deformity . Able to read, understand and speak Urdu. Individuals with symptoms enduring for at least one week .
Key exclusion criteria (2 listed)
- Cognitive impairment or psychiatric illness that hinders understanding of the questionnaire.
- Patients with congenital deformities. Refusal to give informed consent.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| All participants (Aviane)Data will be collected from patients having upper limb pain or disability | Other | Group 1 |
| data collectionData will be collected from patients having upper limb pain or disbility | Other | Group 1 |
Primary outcome
reliability and validity
Time frame: December 2025 to January 2026
To assess the reliability and validity of the Urdu version of the DASH Questionnaire.
1 secondary outcome
cultural adaptation
Time frame: October 2025 to November2025
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 Jan 2026.
- Results publication: PubMed 35665605Basakci Calik B, Demir P, Gur Kabul E, Caglayan BC, Keskin A, Karasu U. Validity and Reliability of the Turkish Version of the DASH-TR Questionnaire in Rheumatoid Arthritis Patients, Based on Rasch Analysis. Int J Rheum Dis. 2022 Aug;25(8):851-860. doi: 10.1111/1756-185X.14358. Epub 2022 Jun 6.
- Results publication: PubMed 36739630Puentes Gutierrez AB, Garcia Bascones M, Jimenez Diaz F, Cuena Boy R, Puentes Gutierrez R. [Validity and reliability of DASH questionnaire in women who suffer from lymphedema as a side effect of a breast cancer treatment]. Rehabilitacion (Madr). 2023 Jul-Sep;57(3):100780. doi: 10.1016/j.rh.2022.100780. Epub 2023 Feb 3. Spanish.
- Individual participant dataSharing planned: No
Related trials for Upper Limb Disability
RecruitingObservational study
Kinematic Analysis of Manual Dexterity
Down Syndrome, Hemiparesis
Not yet recruitingPhase 4
Comparing Three Epidural Steroid Injection Approaches for Lumbar Radicular Pain
Lumbar Disc Herniation, Lumbosacral Radiculopathy
Active, not recruitingObservational study
CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity
Upper Limb Injury
Not yet recruiting
Pepea Pamoja: Cluster-Randomized Trial for Caregivers of Children With Autism in Kenya
Autism Spectrum Disorder, Autism
Not yet recruitingPhase 2
Evaluating the Use of Oral Indapamide to Reduce Disabiltiy Progression in Progressive Multiple Sclerosis (MS)
Multiple Sclerosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Upper Limb Disability, run by Bahria University at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rabia Khan, Masters in Physiotherapy (+923452310047, iamrabiakhan@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
reliability and validity (time frame: December 2025 to January 2026). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07338955, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.